Answers are grounded in this paper and cite their sources.
Finds an avirulent Vibrio cholerae mutant induces protection against cholera in intestinal models, suggesting a potential vaccine.
After mutagenesis with nitrosoguanidine and selection by immuno-halo techniques, an avirulent mutant, designated Texas Star-SR, which produces no detectable A (active; ADP-ribosylating) region of the cholera enterotoxin (choleragen) but produces the B region (choleragenoid) in amounts similar to the hypertoxinogenic wild-type parent Vibrio cholerae (biotype E1 Tor serotype Ogawa), has been isolated. The mutant retains the colonizing ability, motility, prototrophy, and serologic characteristics of the parent. In relevant intestinal experimental models, it has been shown to be avirulent and to induce protection against challenge with virulent cholera vibrios. The mutant appears to be suitable for further evaluation in volunteers as a candidate living enteric vaccine against cholera and related enterotoxic enteropathies.
No takes yet. Share an insight, caveat, or question.
Honda et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: